Massachusetts General Hospital coordinated the first four platform trials within the HEALEY ALS platform to evaluate ...
GLP-1 weight loss drugs like Ozempic and Wegovy are popular with people who want to lose weight. However, there is another ...
A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.
A new study suggests that using weight loss drugs such as Ozempic and Wegovy can lead to less alcohol consumption. The study, ...
Ultragenyx Pharmaceutical RARE reported new findings from an ongoing, pivotal study of its investigational ... Rare Pediatric Disease and Orphan Drug designations in the United States.
μ-VIS X-Ray Imaging Centre, Faculty of Engineering and Physical Sciences, University of Southampton, Southampton SO17 1BJ, U.K. Institute for Life Sciences, University of Southampton, University Road, ...
The study evaluates MRK’s pulmonary arterial hypertension (PAH) drug, Winrevair (sotatercept), for a more advanced version of the disease. This decision is based on strong efficacy data from ...
Next in the study, published in the journal Drug and Alcohol Dependence, were stimulants such as Adderall, Ritalin, and methamphetamine, with an average of 4.4 quit attempts, followed by alcohol ...
"And second, we might find a number of targets for future drugs." The study is being run by French biotech startup Cure51, with backing from the venture capital firm Sofinnova Partners. Nicolas ...
These models allow scientists to study the behavior of the drug and the cancer without relying solely on human trials. By speeding up the process, these simulations provide doctors with valuable ...
Akero Therapeutics reported Monday strong results from a nearly two-year, placebo-controlled study showing its drug efruxifermin reversed liver scarring in patients with cirrhosis caused by the ...
The company also did not disclose safety data from the study. "We believe weight loss of the combined drugs and safety are (the) key metrics investors are looking for," Truist Securities analyst ...